Biaryl substituted triazoles as sodium channel blockers
Details for Australian Patent Application No. 2004221885 (hide)
International Classifications
Event Publications
6 October 2005 PCT application entered the National Phase
PCT publication WO2004/083189 Priority application(s): WO2004/083189
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
22 April 2010 Application Accepted
Published as AU-B-2004221885
3 June 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 May 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
23 September 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 May 2010
30 September 2010 Standard Patent Sealed
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004221891-Monocyclic anilide spirohydantoin CGRP receptor antagonists
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser